Doxorubicin pathways: pharmacodynamics and adverse effects.

Pharmacogenet Genomics. 2011 Jul;21(7):440-6. doi:10.1097/FPC.0b013e32833ffb56

{{ author.authorName }}^{{{getOrganisationIndexOf(author)}}} {{ author.authorName }}^{{{getOrganisationIndexOf(author)}}}

+ et al

[No authors listed]

Author information

null

KEYWORDS: {{ getKeywords(articleDetailText.words) }}

‹ › ×

Sample name	Organism	Experiment title	Sample type	Library instrument	Attributes
Sample name	Organism	Experiment title	Sample type	Library instrument	{{attr}}
{{ dataList.sampleTitle }}	{{ dataList.organism }}	{{ dataList.expermentTitle }}	{{ dataList.sampleType }}	{{ dataList.libraryInstrument }}	{{ showAttributeName(index,attr,dataList.attributes) }}